Arrowhead Pharmaceuticals Inc. (ARWR) Next Earnings Date & Options-Implied ±6.8% Move

$60.49 +0.47% NASDAQ • Public Delayed / 60s Snapshot

Arrowhead Pharmaceuticals Inc. (ARWR) earns a Roarable Rating of B- (Buy) with 71/100 RQD Confidence. High-quality cash engine (41% profit margin, 11% return on capital) with steady institutional support. Even if the broader market gets choppy, the company’s underlying cash engine and big-money support put the odds in buyers’ favor.

ROARABLE B- • BUY Cap $8.54B
INTERACTIVE SCENARIO DECK:
🛡️ Portfolio Crash X-Ray
RQD QUANT TACHOMETERBUY • B-
025507510071
2-of-3 JEV AI Jury Bullish
Cash
SEC
Whale
5-PILLAR SNOWFLAKE RADARRw C · Rk B+
Cash (17)Whales (10)SEC (16)Macro (16)CEO (12)
Each axis scored 0–20
12M PRICE TARGET CONE+5.9% Base Target
$100 Bull$64 Base$50 Bear
🔴 SUNDAY NIGHT PREP • 7:00 PM ET
WHALE OPTIONS TUG-OF-WAR:55% Call Buyers ($2.5M)
45% PutsMax Pain: $59.00
NEXT EST. REPORT: Dec 29, 2026 (~58 DAYS)

Options-Implied Post-Earnings ±6.8% Bell Curve

±$4.11 Expected Swing
$56.38 (-6.8%)Spot $60.49$64.60 (+6.8%)
TRADER CROWD SENTIMENT POLL

Will ARWR Beat & Rip or Miss Next Quarter?

Trailing EPS: $-0.01 • YoY Revenue Growth: 180%

57% Bullish Beat43% Bearish Miss

Recent SEC Reported Revenue, Net Profit & Diluted EPS Cadence

PeriodFiledRevenueNet ProfitFree Cash FlowGross Margin
FY 20252025-09-30$829.4M-$1.6M$156.9M44%
FY 20242024-09-30$3.6M-$599.5M-$604.3M44%
FY 20232023-09-30$240.7M-$205.3M-$164.7M44%
🔴 SUNDAY NIGHT PREP • 7:00 PM ETHosted Live by Perry Belcher + Guest Options & Prop-Trading Strategist

Whale Flow & Momentum Playbook: Trading ARWR & AI Leaders Without Chasing Tops

  • ✓Exact institutional whale strikes & implied earnings range on ARWR this week
  • ✓How active traders scale setups using funded prop-firm accounts instead of risking savings
  • ✓Free bonus: instant RQD Rating Flip alerts on all tracked momentum leaders
RQD INSIDER CLUB UPGRADE$49/YEAR
Want Plain-English AI Custom Indicators, Daily Pro Trader Video Clips & SMS Crash Alerts?
ARWR // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: -18.48%📐 HORIZONTAL RANGE
2026-10-30O $59.75H $61.50L $58.74C $59.90VOL 1.12M
RES: $101.4SUP: $53.70SMA50: $69.79SMA200: $71.73
$98.79$85.11$71.42$57.74$44.05RES $101.4SUP $53.70$59.902026-04-302026-06-152026-07-312026-09-162026-10-30
PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK

ARWR Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure

Share Count & Dilution Monitor (#25)

Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).

Reverse-DCF Expectations Hurdle (#30)
11.2%/yr Implied 5Y Growth

vs. +180.0% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).

Ellis Vennor Setup Ledger (#33)

No active Ellis Vennor swing setup published on ARWR today. View full Setup Ledger →

🦋 Documented & Second-Order Butterfly Connections Open Graph →

No direct multi-tier Butterfly edges indexed yet for ARWR. Explore sector supply chains on /butterfly.

AI Analyst Theses, Washington Policy & Company Video
🎬 No recent verified company-specific video clip queued for ARWR today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →

ARWR Investor FAQ & Complete 8-Part Research Index

100% OPEN ACCESS • SEC EDGAR × CBOE × FRED

When is ARWR's next earnings date?

Based on SEC filing cadence, Arrowhead Pharmaceuticals Inc. (ARWR)'s next quarterly earnings window is estimated around Dec 29, 2026.

How much is ARWR stock expected to move on earnings?

Options markets currently imply a ±6.8% post-earnings move for ARWR, projecting a trading range between $56.38 and $64.6.